WWP2 confers risk to osteoarthritis by affecting cartilage matrix deposition via hypoxia associated genes.


Journal

Osteoarthritis and cartilage
ISSN: 1522-9653
Titre abrégé: Osteoarthritis Cartilage
Pays: England
ID NLM: 9305697

Informations de publication

Date de publication:
01 2023
Historique:
received: 29 06 2022
revised: 12 09 2022
accepted: 28 09 2022
pubmed: 9 10 2022
medline: 21 12 2022
entrez: 8 10 2022
Statut: ppublish

Résumé

To explore the co-expression network of the osteoarthritis (OA) risk gene WWP2 in articular cartilage and study cartilage characteristics when mimicking the effect of OA risk allele rs1052429-A on WWP2 expression in a human 3D in vitro model of cartilage. Co-expression behavior of WWP2 with genes expressed in lesioned OA articular cartilage (N = 35 samples) was explored. By applying lentiviral particle mediated WWP2 upregulation in 3D in vitro pellet cultures of human primary chondrocytes (N = 8 donors) the effects of upregulation on cartilage matrix deposition was evaluated. Finally, we transfected primary chondrocytes with miR-140 mimics to evaluate whether miR-140 and WWP2 are involved in similar pathways. Upon performing Spearman correlations in lesioned OA cartilage, 98 highly correlating genes (|ρ| > 0.7) were identified. Among these genes, we identified GJA1, GDF10, STC2, WDR1, and WNK4. Subsequent upregulation of WWP2 on 3D chondrocyte pellet cultures resulted in a decreased expression of COL2A1 and ACAN and an increase in EPAS1 expression. Additionally, we observed a decreased expression of GDF10, STC2, and GJA1. Proteomics analysis identified 42 proteins being differentially expressed with WWP2 upregulation, which were enriched for ubiquitin conjugating enzyme activity. Finally, upregulation of miR-140 in 2D chondrocytes resulted in significant upregulation of WWP2 and WDR1. Mimicking the effect of OA risk allele rs1052429-A on WWP2 expression initiates detrimental processes in the cartilage shown by a response in hypoxia associated genes EPAS1, GDF10, and GJA1 and a decrease in anabolic markers, COL2A1 and ACAN.

Identifiants

pubmed: 36208715
pii: S1063-4584(22)00861-5
doi: 10.1016/j.joca.2022.09.009
pii:
doi:

Substances chimiques

MicroRNAs 0
WWP2 protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27
Mirn140 microRNA, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-48

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

M Tuerlings (M)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: M.Tuerlings@lumc.nl.

G M C Janssen (GMC)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: G.M.C.Janssen@lumc.nl.

I Boone (I)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: I.Boone@lumc.nl.

M van Hoolwerff (M)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: M.van_Hoolwerff@lumc.nl.

A Rodriguez Ruiz (A)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: A.Rodriguez_Ruiz@lumc.nl.

E Houtman (E)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: E.Houtman@lumc.nl.

H E D Suchiman (HED)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: H.E.D.Suchiman@lumc.nl.

R J P van der Wal (RJP)

Dept. Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: R.J.P.van_der_Wal@lumc.nl.

R G H H Nelissen (RGHH)

Dept. Orthopaedics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: R.G.H.H.Nelissen@lumc.nl.

R Coutinho de Almeida (R)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: R.Coutinho_de_Almeida@lumc.nl.

P A van Veelen (PA)

Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: P.A.van_Veelen@lumc.nl.

Y F M Ramos (YFM)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: Y.F.M.Ramos@lumc.nl.

I Meulenbelt (I)

Dept. of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: i.meulenbelt@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH